On June 15, the National Institutes of Health (NIH) announced the establishment of the “Office of Research Innovation, Validation, and Application” (ORIVA). ORIVA will coordinate NIH-wide efforts to develop, validate, and scale “New Approach Methodologies” (NAMs), including 3D models of human tissue, computer-based tools, and other animal-free methods that can better reflect human biology.

The Polish research and technology company QSAR Lab has developed the open-access database NAMs.network. The developers’ goal was to make knowledge about New Approach Methodologies (NAMs) for hazard characterization easier to find, understand, and use.

A German-American research team led by scientists from the Bernhard Nocht Institute for Tropical Medicine and the Icahn School of Medicine at Mount Sinai in New York has developed brain organoids to investigate the mechanisms that enable the feared Ebola virus to survive long-term in its host.

On June 10, 2026, Humane World for Animals organized an informational event at the European Parliament entitled “Funding for Non-Animal Science: A Moonshot for NAMs.” It was hosted by MEPs Cristina Guarda (Greens/EFA) and Sebastian Everding (The Left). The event was a roundtable discussion on financial support for the accelerated development, validation, and adoption of NAMs in biomedical research and safety testing.